NeOnc has two products in development, namely NEO100 – a purified form of perillyl acid (POH) which is administered to brain ...

The upgraded NHS App, due to be ready in March, will allow almost all patients to contact their GP or hospital for non-urgent ...

That is more than three times higher than last year, but not quite at the same level that was reached in the 2022-2023 flu season, according to the UK Health Security Agency (UKHSA), which has called ...

Alex Brenchat, PhD, is VP and practice area lead for local pharmacovigilance services at PharmaLex. Brenchat has more than 20 ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...

Every new drug entering clinical trials requires careful decision-making, particularly regarding trial design and resource ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possible’.

This tiered approach allows investors to engage at the level they’re most comfortable with, sparking their interest with a ...

The team from the University of Bath in the UK, Poland's Kozminski Academy and Lund University in Sweden have concluded that ...

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.